ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $271,000 | +5.4% | 21,745 | +15.9% | 0.01% | -20.0% |
| Q3 2016 | $257,000 | +35.3% | 18,756 | +0.1% | 0.02% | +36.4% |
| Q2 2016 | $190,000 | +69.6% | 18,729 | +6.5% | 0.01% | 0.0% |
| Q1 2016 | $112,000 | +10.9% | 17,594 | +9.4% | 0.01% | -8.3% |
| Q4 2015 | $101,000 | -1.9% | 16,080 | -8.8% | 0.01% | +9.1% |
| Q3 2015 | $103,000 | -28.0% | 17,625 | +1.7% | 0.01% | -21.4% |
| Q2 2015 | $143,000 | +3.6% | 17,322 | +3.4% | 0.01% | -17.6% |
| Q1 2015 | $138,000 | +24.3% | 16,749 | +4.0% | 0.02% | 0.0% |
| Q4 2014 | $111,000 | +27.6% | 16,100 | +0.1% | 0.02% | +30.8% |
| Q3 2014 | $87,000 | -14.7% | 16,076 | -0.0% | 0.01% | -13.3% |
| Q2 2014 | $102,000 | -39.3% | 16,083 | -22.8% | 0.02% | -48.3% |
| Q1 2014 | $168,000 | +17.5% | 20,835 | -0.7% | 0.03% | +20.8% |
| Q4 2013 | $143,000 | -52.0% | 20,990 | +29.7% | 0.02% | -75.0% |
| Q3 2013 | $298,000 | – | 16,179 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |